Loading cart

Priority-driven Collaborative Cancer Research Scheme

Cancer Australia has developed the Priority-driven Collaborative Cancer Research Scheme to support research that reduces the impact of cancer on the community and improves outcomes for people affected by cancer.

The Priority-driven Collaborative Cancer Research Scheme is an innovative annual national research project grants funding scheme which brings together government and other funders of cancer research to collaboratively fund cancer research in Australia.

Aims and Outcomes

This funding scheme helps to:

  • coordinate funding of priority-driven cancer research at the national level,
  • foster collaboration between cancer researchers to build Australia’s cancer research capacity, and
  • foster consumer participation in cancer research, from design to implementation.

Working with the National Health and Medical Research Council (NHMRC)

This research scheme is managed by Cancer Australia and the agency collaborates with the NHMRC in this grant scheme. The NHMRC facilitates registration and initial assessment of applications, and endorses grants funded through this scheme in recognition of their scientific merit.

2016 PdCCRS Round now closed

Announcement of Research Priorities

Cancer Australia and its Funding Partners are pleased to announce the research priorities for the 2016 round of the Priority-driven Collaborative Cancer Research Scheme (DOC 1 MB)

This funding scheme helps to:

  • fund research in tumour areas that place a high burden of disease on the Australian community;
  • fund cancer research projects that directly relate to the identified priorities of Cancer Australia and/or its Funding Partners; and
  • fund research that can directly improve cancer outcomes by influencing clinical practice, policy and/or care.

2016 PdCCRS Funding Partners

Funding will be available for research that addresses the priorities of Cancer Australia and the following Funding Partners:

  • Australasian Sarcoma Study Group
  • Cancer Council Australia
  • Cancer Council NSW    
  • Cure Cancer Australia
  • National Breast Cancer Foundation
  • The Kids' Cancer Project

Please note that the call for applications to the 2016 round of the Priority-driven Collaborative Cancer Research Scheme (PdCCRS) is now closed.

Successful applicants for 2015 Round

On 17 December 2015, the Australian Government announced successful applicants for the 2015 round of the Priority-driven Collaborative Cancer Research Scheme (PDF 132 KB) (DOC 52 KB) proudly funded by Cancer Council Australia, Cancer Council NSW, Cure Cancer Australia Foundation, National Breast Cancer Foundation, Prostate Cancer Foundation of Australia, and The Kids’ Cancer Project. The successful applicants are as follows:

Agar, Meera    
Braeside Hospital    
Phase II randomised placebo-controlled, double blind, multisite study of acetazolamide versus placebo for management of cerebral oedema in recurrent and/or progressive HGG requiring treatment with dexamethasone – The ACED trial
Funded by Cancer Australia

Beck, Dominik    
Lowy Cancer Research Centre    
The role of long-non coding RNAs in Acute Myeloid Leukaemia
Co-funded by Cancer Australia and Cure Cancer Australia

Bray, Laura    
Queensland University of Technology
Dissecting the molecular and cellular mechanisms of angiogenesis and bone metastasis in a bioengineered microenvironment model of prostate cancer
Funded by Cure Cancer Australia

Bonder, Claudine    
University of South Australia    
Targeting the IL-3/IL-3 receptor axis to prevent breast cancer progression
Co-funded by Cancer Australia and National Breast Cancer Foundation

Broughton, Sophie    
St Vincent’s Institute of Medical Research        
Discovering the molecular basis of IL-3 receptor signalling
Funded by Cure Cancer Australia

Campbell, Ian    
Peter MacCallum Cancer Centre
Resolution of the missing heritability of breast cancer
Co-funded by Cancer Australia and National Breast Cancer Foundation

Foroudi, Farshad
Olivia Newton-John Cancer and Wellness Centre
A mutilstage, multicentre international Randomised trial of Conventional care Or Radioablation (stereotactic body radiotherapy) for Extra-cranial oligometastatic disease in lung, breast and prostate cancer (CORE)
Funded by Cancer Australia

Gottardo, Nicholas    
University of Western Australia and Telethon Kids Institute
Improving the cure rates of childhood brain cancer
Co-funded by Cancer Australia, The Kids’ Cancer Project and Cure Cancer Australia

Halkett, Georgia    
Curtin University of Technology        
Confidence to Care: A multi-state randomised controlled trial of structured nurse-led home-based support and education for carers of people with high grade glioma.
Funded by Cancer Australia

Hilton, Heidi    
Westmead Millennium Institute
Generation and use of novel model systems to study steroid hormone action in the breast
Co-funded by Cancer Australia and Cure Cancer Australia

Lesterhuis, Willem    
University of Western Australia    
Identification of the molecular networks that drive mesothelioma invasion
Co-funded by Cancer Australia and Cure Cancer Australia

Lim, Elgene    
Olivia Newton-John Cancer Research Institute    
A novel approach to overcome treatment-resistance in breast cancer
Co-funded by Cancer Australia and National Breast Cancer Foundation

Macrae, Finlay
The Royal Melbourne Hospital    Melbourne Health
CaPP3: a randomized double blind dose inferiority trial of aspirin in Lynch Syndrome
Co-funded by Cancer Australia and Cancer Council NSW

Mazza, Danielle    
Monash University    
LEAD – Lung cancer diagnostic and treatment pathways: a comparison between CALD and Anglo-Australian patients
Funded by Cancer Council Australia

Mileshkin, Linda    
Peter MacCallum Cancer Centre
The PEARL trial: Palliative care early in advanced lung cancers
Funded by Cancer Australia

Mileshkin, Linda    
Peter MacCallum Cancer Centre    
ICON9: A phase 3 randomised trial of cediranib and olaparib maintenance in patients with relapsed platinum sensitive ovarian cancer
Funded by Cancer Australia

Obermair, Andreas    
University of Queensland    
Long-term follow-up of the Laparoscopic Approach to Carcinoma of the Endometrium (LACE) Trial – survival outcomes
Funded by Cancer Australia

Pajic, Marina    
Garvan Institute of Medical Research/ The Kinghorn Cancer Centre    
From mice to men: biomarker-driven classification of pancreatic cancer to define the gemcitabine/ nab-paclitaxel-responsive molecular subtype.
Funded by Cancer Australia

Patel, Manish    
Westmead Hospital    
Developing a patient-reported symptom index for non-muscle invasive bladder cancer
Co-funded by Cancer Australia and Cancer Council NSW

Phillips, Kelly-Anne    
Peter MacCallum Cancer Centre
Translating Evidence into Practice: Optimising and facilitating prevention and screening in women with a strong family history of breast cancer
Co-funded by Cancer Australia and National Breast Cancer Foundation

Shannon, Jennifer    
Nepean Cancer Care Centre    
Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 Trial)
Funded by Cancer Australia

Shaw, Peter
The Sydney Children’s Hospital Network
Counting the cost of curing childhood ALL by transplantation
Funded by Cancer Australia

Slaney, Clare    
Peter MacCallum Cancer Centre
Targeting the tumour microenvironment to enhance immunotherapy against cancer
Funded by Cure Cancer Australia

Sobinoff, Alexander    
Children’s Medical Research Institute
Developing a rapid and quantitative telomere length test to measure chemotherapeutic response to telomerase inhibition
Co-funded by Cancer Australia and Cure Cancer Australia

Tikoo, Shwete    
Centenary Institute of Cancer Medicine and Cell Biology    
Targeting breast cancer metastasis: Delineating the role of “Perivascular Macrophages” in tumour cell metastasis
Funded by Cure Cancer Australia

Vandyke, Kate    
University of Adelaide
Mechanisms governing dissemination and relapse in multiple myeloma: the role of hypoxia and the CCR1/CXCR4 axis
Funded by Cure Cancer Australia

Woods, Susan    
University of Adelaide
Do Gremlin1 expressing fibroblasts drive tumourigenesis?
Funded by Cure Cancer Australia
 

Cancer Australia's funding partners and successful applicants in previous PdCCRS rounds

Further information